181 related articles for article (PubMed ID: 31818816)
1. Synergistic Activity of Exebacase (CF-301) in Addition to Daptomycin against Staphylococcus aureus in a Neutropenic Murine Thigh Infection Model.
Asempa TE; Abdelraouf K; Carabeo T; Schuch R; Nicolau DP
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818816
[TBL] [Abstract][Full Text] [Related]
2. Efficacy assessment of lysin CF-296 in addition to daptomycin or vancomycin against Staphylococcus aureus in the murine thigh infection model.
Asempa TE; DeRosa NA; Cassino C; Lehoux D; Schuch R; Nicolau DP
J Antimicrob Chemother; 2021 Sep; 76(10):2622-2628. PubMed ID: 34223628
[TBL] [Abstract][Full Text] [Related]
3. Exebacase in Addition to Daptomycin Is More Active than Daptomycin or Exebacase Alone in Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rats.
Karau MJ; Schmidt-Malan SM; Yan Q; Greenwood-Quaintance KE; Mandrekar J; Lehoux D; Schuch R; Cassino C; Patel R
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358593
[TBL] [Abstract][Full Text] [Related]
4. Considerations about the Use of a Loading Dose of Daptomycin in a Neutropenic Murine Thigh Infection Model with Methicillin-Resistant Staphylococcus aureus Infection.
Kato H; Hagihara M; Murakami E; Suematsu H; Nishiyama N; Koizumi Y; Yamagishi Y; Uno B; Mikamo H
Chemotherapy; 2018; 63(1):13-19. PubMed ID: 29130946
[TBL] [Abstract][Full Text] [Related]
5. Exebacase Is Active
Swift SM; Sauve K; Cassino C; Schuch R
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0272320. PubMed ID: 34228536
[TBL] [Abstract][Full Text] [Related]
6. Exebacase Demonstrates
Watson A; Sauve K; Cassino C; Schuch R
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712212
[No Abstract] [Full Text] [Related]
7. Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.
Dandekar PK; Tessier PR; Williams P; Nightingale CH; Nicolau DP
J Antimicrob Chemother; 2003 Sep; 52(3):405-11. PubMed ID: 12917254
[TBL] [Abstract][Full Text] [Related]
8. In vivo pharmacodynamics of torezolid phosphate (TR-701), a new oxazolidinone antibiotic, against methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains in a mouse thigh infection model.
Louie A; Liu W; Kulawy R; Drusano GL
Antimicrob Agents Chemother; 2011 Jul; 55(7):3453-60. PubMed ID: 21502615
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of human simulated exposures of ceftaroline administered at 600 milligrams every 12 hours against phenotypically diverse Staphylococcus aureus isolates.
Keel RA; Crandon JL; Nicolau DP
Antimicrob Agents Chemother; 2011 Sep; 55(9):4028-32. PubMed ID: 21670184
[TBL] [Abstract][Full Text] [Related]
10. Effect of the Lysin Exebacase on Cardiac Vegetation Progression in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Endocarditis as Determined by Echocardiography.
Shah SU; Xiong YQ; Abdelhady W; Iwaz J; Pak Y; Schuch R; Cassino C; Lehoux D; Bayer AS
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32340988
[TBL] [Abstract][Full Text] [Related]
11. Exebacase in Addition to Daptomycin against MRSA.
Kebriaei R; Stamper KC; Lev KL; Morrisette T; Abdul-Mutakabbir JC; Schuch R; Lehoux D; Rybak MJ
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0012821. PubMed ID: 34398668
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of Exebacase (CF-301) against clinical Staphylococcus aureus surveillance isolates from the United States, Europe, and Latin America, 2015-2017.
Traczewski M; Oh J; Cassino C; Schuch R
Diagn Microbiol Infect Dis; 2019 Dec; 95(4):114879. PubMed ID: 31466875
[TBL] [Abstract][Full Text] [Related]
13.
Lepak AJ; Zhao M; Marchillo K; VanHecker J; Andes DR
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036691
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus.
Lepak AJ; Seiler P; Surivet JP; Ritz D; Kohl C; Andes DR
Antimicrob Agents Chemother; 2016 Jun; 60(6):3626-32. PubMed ID: 27044547
[TBL] [Abstract][Full Text] [Related]
15. High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.
Miró JM; Entenza JM; Del Río A; Velasco M; Castañeda X; Garcia de la Mària C; Giddey M; Armero Y; Pericàs JM; Cervera C; Mestres CA; Almela M; Falces C; Marco F; Moreillon P; Moreno A;
Antimicrob Agents Chemother; 2012 Aug; 56(8):4511-5. PubMed ID: 22644033
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model.
Banevicius MA; Kaplan N; Hafkin B; Nicolau DP
J Chemother; 2013 Feb; 25(1):26-31. PubMed ID: 23433441
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of tigecycline against phenotypically diverse Staphylococcus aureus isolates in a murine thigh model.
Crandon JL; Banevicius MA; Nicolau DP
Antimicrob Agents Chemother; 2009 Mar; 53(3):1165-9. PubMed ID: 19114676
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.
Andes D; Craig WA
Antimicrob Agents Chemother; 2006 Apr; 50(4):1376-83. PubMed ID: 16569855
[TBL] [Abstract][Full Text] [Related]
19. Effect of High Blood Glucose Level on the Antimicrobial Activity of Daptomycin against Staphylococcus aureus in Streptozotocin-Induced Diabetic Mice.
Kondo T; Hagihara M; Esaka Y; Yamamoto T; Uno B; Yamagishi Y; Mikamo H
Jpn J Infect Dis; 2020 May; 73(3):205-209. PubMed ID: 31875609
[TBL] [Abstract][Full Text] [Related]
20. Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity.
Rose WE; Schulz LT; Andes D; Striker R; Berti AD; Hutson PR; Shukla SK
Antimicrob Agents Chemother; 2012 Oct; 56(10):5296-302. PubMed ID: 22869564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
